Overview
McDermott Will & Emery has advised AgenT-biotech, a pioneering developer of a blood-based diagnostic test for the silent phase of Alzheimer’s disease, on its collaboration with INOVIE Group, the world leader in clinical laboratory networks, to revolutionize the detection of Alzheimer’s disease.
The McDermott team on this operation was composed of Anne-France Moreau and Emmanuelle Trombe, partners, and Caroline Noyrez, associate.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
